FDA Approved: TALVEY — Supplemental Application (Janssen Biotech, Inc.)

View source ↗

Summary

FDA approved a supplemental application for TALVEY (talquetamab) from Janssen Biotech, Inc. The supplemental approval updates the labeling for TALVEY.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• TALVEY (talquetamab)

Snippet

SUPPL AP for TALVEY (TALQUETAMAB)